Chapter 42 Diseases of Muscle

  1. Holmgren N, Valberg S. 1992. Measurement of serum myoglobin concentrations in horses by immunodiffusion. Am J Vet Res 53:957. PUBMED Abstract
  2. Rasanen LA. 1995. Exercise-induced purine nucleotide degradation and changes in myocellular protein release. Equine Vet J Suppl 18:235.
  3. Harris PA, Snow DH. 1991. Role of electrolyte imbalances in the pathophysiology of the equine rhabdomyolysis syndrome, pp 435-442. In Persson S, Lindholm A, Jeffcott LB (eds), Equine exercise physiology, ed 3. ICEEP Publications, Davis, CA.
  4. McKenzie EC, Valberg SJ, Godden SM, et al. 2003. Comparison of volumetric urine collection versus single-sample urine collection in horses consuming diets varying in cation-anion balance. Am J Vet Res 64:284. PUBMED Abstract
  5. McKenzie EC, Valberg SJ, Godden SM, et al. 2002. Plasma and urine electrolyte and mineral concentrations in Thoroughbred horses with recurrent exertional rhabdomyolysis after consumption of diets varying in cation-anion balance. Am J Vet Res 63:1053. PUBMED Abstract
  6. Valberg S, Jonsson L, Lindholm A, Holmgren N. 1993. Muscle histopathology and plasma aspartate aminotransferase, creatine kinase and myoglobin changes with exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J 25:11. PUBMED Abstract
  7. Valberg SJ, Mickelson JR, Gallant EM, et al. 1999. Exertional rhabdomyolysis in Quarter Horses and Thoroughbreds: one syndrome, multiple aetiologies. Equine Vet J Suppl 30:533. PUBMED Abstract
  8. Valberg SJ, MacLeay JM, Mickelson JR. 1997. Polysaccharide storage myopathy associated with exertional rhabdomyolysis in horses. Comp Cont Educ Pract Vet 19:1077.
  9. Wijnberg ID, van der Kolk JH, Franssen H, et al. 2003. Needle electromyography in the horse compared with its principles in man: a review. Equine Vet J 35:9. PUBMED Abstract
  10. Wijnberg ID, Franssen H, Jansen GH, et al. 2003. Quantitative electromyographic examination in myogenic disorders of 6 horses. J Vet Intern Med 17:185. PUBMED Abstract
  11. Wijnberg ID, Franssent H, van der Kolk JH, Breukink HJ. 2002. Quantitative motor unit action potential analysis of skeletal muscles in the warmblood horse. Equine Vet J 34:556. PUBMED Abstract
  12. Wijnberg ID, Back W, de Jong M, et al. 2004. The role of electromyography in clinical diagnosis of neuromuscular locomotor problems in the horse. Equine Vet J 36:718. PUBMED Abstract
  13. Andrews FM, Fenner WR. 1987. Indication and use of electrodiagnostic aids in neurologic disease. Vet Clin North Am Equine Pract 3:293. PUBMED Abstract
  14. Valberg SJ, Dyson S. 2003. Skeletal muscle and lameness, pp 723-743. In Ross M, Dyson S (eds), Lameness in the horse, ed 1. Saunders, Philadelphia, PA.
  15. Morris E, Seeherman HJ, O'Callaghan MW, et al. 1991. Scintigraphic identification of skeletal muscle damage in horses 24 hours after strenuous exercise. Equine Vet J 23:347. PUBMED Abstract
  16. Cumming WJK, Fulthorpe JJ, Hudgson P, et al. 1994. Color atlas of muscle pathology, ed 1. Mosby-Wolfe, London.
  17. Cardinet GH III, Holliday TA. 1979. Neuromuscular diseases of domestic animals: a summary of muscle biopsies from 159 cases. Ann N Y Acad Sci 317:290. PUBMED Abstract
  18. Firshman AM, Valberg SJ, Bender JB, et al. 2006. Comparison of histopathologic criteria and skeletal muscle fixation techniques for the diagnosis of polysaccharide storage myopathy in horses. Vet Pathol 43:257. PUBMED Abstract
  19. Lentz LR, Valberg SJ, Balog EM, et al. 1999. Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 60:992. PUBMED Abstract
  20. Hildebrand SV, Arpin D, Cardinet G III. 1990. Contracture test and histologic and histochemical analyses of muscle biopsy specimens from horses with exertional rhabdomyolysis. J Am Vet Med Assoc 196:1077. PUBMED Abstract
  21. Beech J, Lindborg S, Fletcher JE, et al. 1993. Caffeine contractures, twitch characteristics and the threshold for Ca(2+)-induced Ca2+ release in skeletal muscle from horses with chronic intermittent rhabdomyolysis. Res Vet Sci 54:110. PUBMED Abstract
  22. Layzer RB. 1994. Muscle pain, cramps and fatigue, pp 1754-1768. In Engel AG, Franzini-Armstrong C (eds), Myology, ed 2. McGraw-Hill, Inc, New York, NY.
  23. Cannon SC, Hayward LJ, Beech J, et al. 1995. Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis. J Neurophysiol 73:1892. PUBMED Abstract
  24. Bryant SH, Conte-Camerino D. 1991. Chloride channel regulation in the skeletal muscle of normal and myotonic goats. Pflugers Arch 417:605. PUBMED Abstract
  25. Hulland TJ. 1985. Muscle and tendons, p 139. In Jubb KVF, Kennedy PC, Palmer N (eds), Pathology of domestic animals, ed 3. Academic Press, Orlando, FL.
  26. Lewis SS, Valberg SJ, Nielsen IL. 2007. Suspected immune-mediated myositis in horses. J Vet Intern Med 21:495. PUBMED Abstract
  27. Warren JD, Blumbergs PC, Thompson PD. 2002. Rhabdomyolysis: a review. Muscle Nerve 25:332. PUBMED Abstract
  28. Spier SJ, Carlson GP, Holliday TA, et al. 1990. Hyperkalemic periodic paralysis in horses. J Am Vet Med Assoc 197:1009. PUBMED Abstract
  29. Reed SM, Hegreberg GA, Bayly WM, et al. 1988. Progressive myotonia in foals resembling human dystrophia myotonica. Muscle Nerve 11:291. PUBMED Abstract
  30. Jamison JM, Baird JD, Smith-Maxie LL, et al. 1987. A congenital form of myotonia with dystrophic changes in a quarterhorse. Equine Vet J 19:353. PUBMED Abstract
  31. Madigan JE, Valberg SJ, Ragle C, Moody JL. 1995. Muscle spasms associated with ear tick (Otobius megnini) infestations in five horses. J Am Vet Med Assoc 207:74. PUBMED Abstract
  32. Keith JR. 1981. Spastic paresis in beef and dairy cattle. Vet Med Small Anim Clin 76:1043. PUBMED Abstract
  33. Griffiths IB. 2005. Spastic paresis in calves. Vet Rec 156:786. PUBMED Abstract
  34. Ledoux JM. 2001. Bovine spastic paresis: etiological hypotheses. Med Hypotheses 57:573. PUBMED Abstract
  35. Wijeratine WV. 1976. Letter: heritability of spastic paresis. Vet Rec 98:139. PUBMED Abstract
  36. Bourke CA. 1996. Bovine asymmetric hind limb paresis, a presumptive in-utero plant poisoning. Aust Vet J 74:42. PUBMED Abstract
  37. Baird JD, Firshman AM, Valberg SJ. 2006. Shivers (shivering) in the horse: a review. Proc Am Assoc Equine Pract 52:359.
  38. Lehmann-Horn F, Jurkat-Rott K, Rudel R. 2002. Periodic paralysis: understanding channelopathies. Curr Neurol Neurosci Rep 2:61. PUBMED Abstract
  39. Lehmann-Horn F, Jurkat-Rott K. 1999. Voltage-gated ion channels and hereditary disease. Physiol Rev 79:1317. PUBMED Abstract
  40. Bryant SH, Lipicky RJ, Herzog WH. 1968. Variability of myotonic signs in myotonic goats. Am J Vet Res 29:2371. PUBMED Abstract
  41. Schooley EK, MacLeay JM, Cuddon P, et al. 2004. Myotonia congenita in a foal. J Equine Vet Science 24:483.
  42. Bryant SH. 1979. Myotonia in the goat. Ann N Y Acad Sci 317:314. PUBMED Abstract
  43. Smith MC, Sherman DM. 1994. Musculoskeletal system, pp 109-110. In Goat medicine. Lea & Febiger, Malvern, PA.
  44. Wijnberg ID, Owczarek-Lipska M, Sacchetto R, et al. 2012. A missense mutation in the skeletal muscle chloride channel 1 (CLCN1) as candidate causal mutation for congenital myotonia in a New Forest pony. Neuromuscul Disord 22:361. PUBMED Abstract
  45. Montagna P, Liguori R, Monari L et al. 2001. Equine muscular dystrophy with myotonia. Clin Neurophysiol 112:294. PUBMED Abstract
  46. Day JW, Ranum LP. 2005. Genetics and molecular pathogenesis of the myotonic dystrophies. Curr Neurol Neurosci Rep 5:55. PUBMED Abstract
  47. Day JW, Ranum LP. 2005. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15:5. PUBMED Abstract
  48. Beech J, Fletcher JE, Tripolitis L, et al. 1992. Effects of phenytoin in two myotonic horses with hyperkalemic periodic paralysis. Muscle Nerve 15:932. PUBMED Abstract
  49. DeLahunta A. 1983. Veterinary neuroanatomy and clinical neurology, ed 2. WB Saunders, Philadelphia, PA.
  50. Hegreberg GA, Reed SM. 1990. Skeletal muscle changes associated with equine myotonic dystrophy. Acta Neuropathol (Berl) 80:426. PUBMED Abstract
  51. Meyer TS, Fedde MR, Cox JH, et al. 1999. Hyperkalaemic periodic paralysis in horses: a review. Equine Vet J 31:362. PUBMED Abstract
  52. Naylor JM. 1994. Equine hyperkalemic periodic paralysis: review and implications. Can Vet J 35:279. PUBMED Abstract
  53. Rudolph JA, Spier SJ, Byrns G, et al. 1992. Linkage of hyperkalaemic periodic paralysis in Quarter Horses to the horse adult skeletal muscle sodium channel gene. Anim Genet 23:241. PUBMED Abstract
  54. Cox JH. 1986. An episodic weakness in four horses associated with intermittent serum hyperkalemia and the similarity of the disease to hyperkalemic periodic paralysis in man. Proceedings of the Annual Convention of the American Association of Equine Practitioners 31:383.
  55. Tryon RC, Penedo MC, McCue ME, et al. 2009. Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses. J Am Vet Med Assoc 234:120. PUBMED Abstract
  56. Naylor JM. 1994. Selection of Quarter Horses affected with hyperkalemic periodic paralysis by show judges. J Am Vet Med Assoc 204:926. PUBMED Abstract
  57. Groves L. 2007. HYPP: someone else's problem? Quarter Horse J 1:59.
  58. Reynolds AJ. 2007. Equine hyperkalemic periodic paralysis (HYPP): overview and management strategies. [WWW page]. Library/Horse Equine HYPP.htm, accessed Nov 18, 2013.
  59. Carr EA, Spier SJ, Kortz GD, et al. 1996. Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. J Am Vet Med Assoc 209:798. PUBMED Abstract
  60. Naylor JM. 1997. Hyperkalemic periodic paralysis. Vet Clin North Am Equine Pract 13:129. PUBMED Abstract
  61. Pickar JG, Spier SJ, Snyder JR, et al. 1991. Altered ionic permeability in skeletal muscle from horses with hyperkalemic periodic paralysis. Am J Physiol 260(5 Pt 1):C926. PUBMED Abstract
  62. Reynolds JA, Potter GD, Greene LW. 1998. Genetic-diet interactions in the hyperkalemic periodic paralysis syndrome in Quarter Horses fed varying amounts of potassium, III. The relationship between plasma potassium concentration and HYPP symptoms. J Equine Vet Sci 18:731.
  63. Ott EA. 2007. National Research Council: nutrient requirements of horses. The National Academies Press, Washington, DC.
  64. Zhou J, Spier SJ, Beech J, et al. 1994. Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis. Hum Mol Genet 3:1599. PUBMED Abstract
  65. Peek SF, Divers TJ, Guard C, et al. 2000. Hypokalemia, muscle weakness, and recumbency in dairy cattle. Vet Ther 1:235. PUBMED Abstract
  66. Michell AR. 1998. Hypokalaemia in cattle. Vet Rec 143:540. PUBMED Abstract
  67. Sattler N, Fecteau G, Girard C, et al. 1998. Description of 14 cases of bovine hypokalaemia syndrome. Vet Rec 143:503. PUBMED Abstract
  68. Sieb JP, Penn AS. 2004. Myoglobinuria, pp 1677-1692. In Engel AG, Franzini-Armstrong C (eds), Myology, ed 3. McGraw-Hill, New York, NY.
  69. Carlson GP. 1985. Medical problems associated with protracted heat and work stress in horses. #84. Proceedings of the Fifth Annual Association of Equine Sports Medicine, Feb 27, Reno, NV.
  70. Foreman JH. 1998. The exhausted horse syndrome. Vet Clin North Am Equine Pract 14:205. PUBMED Abstract
  71. McCutcheon LJ, Geor RJ. 1998. Sweating. Fluid and ion losses and replacement. Vet Clin North Am Equine Pract 14:75. PUBMED Abstract
  72. McCutcheon LJ, Geor RJ, Hare MJ, et al. 1995. Sweating rate and sweat composition during exercise and recovery in ambient heat and humidity. Equine Vet J Suppl 153. PUBMED Abstract
  73. Schott HC, McGlade KS, Molander HA, et al. 1997. Body weight, fluid, electrolyte, and hormonal changes in horses competing in 50- and 100-mile endurance rides. Am J Vet Res 58:303. PUBMED Abstract
  74. Schott HC, Hinchcliff KW. 1998. Treatments affecting fluid and electrolyte status during exercise. Vet Clin North Am Equine Pract 14:175. PUBMED Abstract
  75. Carlson GP. 1987. Synchronous diaphragmatic flutter, pp 485-486. In Robinson NE (ed), Current therapy in equine medicine, ed 2. WB Saunders, Philadelphia, PA.
  76. Mansmann RA, Carlson GP, White NA, et al. 1974. Synchronous diaphragmatic flutter in horses. J Am Vet Med Assoc 165:265. PUBMED Abstract
  77. Hudson NP, Church DB, Trevena J, et al. 1999. Primary hypoparathyroidism in two horses. Aust Vet J 77:504. PUBMED Abstract
  78. White NA, White SL. 1975. Atrioventricular dissociation with synchronous diaphragmatic flutter in a horse. Vet Med Small Anim Clin 70:967. PUBMED Abstract
  79. Brewer BD. 1987. Disorders in calcium metabolism, pp 189-192. In Robinson NE (ed), Current therapy in equine medicine, ed 2. WB Saunders, Philadelphia, PA.
  80. Baird JD. 1971. Lactation tetany (eclampsia) in a Shetland pony mare. Aust Vet J 47:402. PUBMED Abstract
  81. Grubb TL, Foreman JH, Benson GJ, et al. 1996. Hemodynamic effects of calcium gluconate administered to conscious horses. J Vet Intern Med 10:401. PUBMED Abstract
  82. Erwin BG. 1986. Clostridial bacteria and clostridial myositis, pp 567-570. In Berg JN (ed), Current veterinary therapy (food animal practice), ed 2. WB Saunders, Philadelphia, PA.
  83. Blood DC, Radostis OM, Henderson JA. 1983. Veterinary medicine, ed 6. Baillière Tindall, London.
  84. Peek SF, Semrad SD, Perkins GA. 2003. Clostridial myonecrosis in horses (37 cases 1985-2000). Equine Vet J 35:86. PUBMED Abstract
  85. Williams BM. 1977. Clostridial myositis in cattle: bacteriology and gross pathology. Vet Rec 100:90. PUBMED Abstract
  86. Rebhun WC, Shin SJ, King JM, et al. 1985. Malignant edema in horses. J Am Vet Med Assoc 187:732. PUBMED Abstract
  87. Vengust M, Arroyo LG, Weese JS, et al. 2003. Preliminary evidence for dormant clostridial spores in equine skeletal muscle. Equine Vet J 35:514. PUBMED Abstract
  88. Slack JA, McGuirk SM, Erb HN, et al. 2005. Biochemical markers of cardiac injury in normal, surviving septic, or nonsurviving septic neonatal foals. J Vet Intern Med 19:577. PUBMED Abstract
  89. Sponseller BT, Valberg SJ, Tennent-Brown BS, et al. 2005. Severe acute rhabdomyolysis associated with Streptococcus equi infection in four horses. J Am Vet Med Assoc 227:1800. PUBMED Abstract
  90. Valberg SJ, Bullock P, Hogetvedt W, et al. 1996. Myopathies associated with Streptococcus equi infections in horses, pp 292-293. Proc Am Assoc Equine Pract.
  91. Sweeney CR, Timoney JF, Newton JR, et al. 2005. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med 19:123. PUBMED Abstract
  92. Al-Ghamdi GM, Kapur V, Ames TR, et al. 2000. Use of repetitive sequence-based polymerase chain reaction for molecular epidemiologic analysis of Streptococcus equi subspecies equi. Am J Vet Res 61:699. PUBMED Abstract
  93. Adams EM, Gudmundsson S, Yocum DE, et al. 1985. Streptococcal myositis. Arch Intern Med 145:1020, 1985. PUBMED Abstract
  94. Pusterla N, Watson JL, Affolter VK, et al. 2003. Purpura haemorrhagica in 53 horses. Vet Rec 153:118. PUBMED Abstract
  95. Kaese HJ, Valberg SJ, Hayden DW, et al. 2005. Infarctive purpura hemorrhagica in five horses. J Am Vet Med Assoc 226:1893, 1845. PUBMED Abstract
  96. Galan JE, Timoney JF. 1985. Immune complexes in purpura hemorrhagica of the horse contain IgA and M antigen of Streptococcus equi. J Immunol 135:3134. PUBMED Abstract
  97. Barrott MJ, Brooks HW, McGowan CM. 2004. Suspected immune-mediated myositis in a pony. Equine Vet Educ April 80.
  98. Valberg SJ. 1999. Spinal muscle pathology. Vet Clin North Am Equine Pract 15:87. PUBMED Abstract
  99. Harris PA. 1990. An outbreak of the equine rhabdomyolysis syndrome in a racing yard. Vet Rec 127:468. PUBMED Abstract
  100. Freestone JF, Carlson GR. 1991. Muscle disorders in the horse: a retrospective study. Equine Vet J 23:86. PUBMED Abstract
  101. Dubey JP, Fayer R. 1986. Sarcocystosis, toxoplasmosis, and cryptosporidiosis in cattle. Vet Clin North Am Food Anim Pract 2:293. PUBMED Abstract
  102. Fayer R, Elsasser TH. 1991. Bovine sarcocystosis: how parasites negatively affect growth. Parasitol Today 7:250. PUBMED Abstract
  103. Fayer R, Dubey JP. 1982. Development of Sarcocystis fayeri in the equine. J Parasitol 68:856. PUBMED Abstract
  104. Traub-Dargatz JL, Schlipf JW Jr, Granstrom DE, et al. 1994. Multifocal myositis associated with Sarcocystis sp. in a horse. J Am Vet Med Assoc 205:1574. PUBMED Abstract
  105. Fayer R, Johnson AJ. 1975. Effect of amprolium on acute sarcocystosis in experimentally infected calves. J Parasitol 61:932. PUBMED Abstract
  106. McMurray CH, Rice DA. 1982. Vitamin E and selenium deficiency diseases. Irish Vet J 36:57.
  107. Dill SG, Rebhun WC. 1985. White muscle disease in foals. Comp Cont Educ Pract Vet 7:S627.
  108. Maylin GA, Rubin DS, Lein DH. 1980. Selenium and vitamin E in horses. Cornell Vet 70:272. PUBMED Abstract
  109. Perkins G, Valberg SJ, Madigan JM, et al. 1998. Electrolyte disturbances in foals with severe rhabdomyolysis. J Vet Intern Med 12:173. PUBMED Abstract
  110. Maas J, Galey FD, Peauroi JR, et al. 1992. The correlation between serum selenium and blood selenium in cattle. J Vet Diagn Invest 4:48. PUBMED Abstract
  111. Taylor RF, Puls R, MacDonald KR. 1979. Bovine abortions associated with selenium deficiency in western Canada, pp 77-94. Proc Amer Assoc Vet Lab Diagnosticians.
  112. Moncada S, Vane JR. 1979. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 300:1142. PUBMED Abstract
  113. Burk RF, Hill KE. 1993. Regulation of selenoproteins. Annu Rev Nutr 13:65. PUBMED Abstract
  114. Campbell DT, Maas J, Weber DW, et al. 1990. Safety and efficacy of two sustained-release intrareticular selenium supplements and the associated placental and colostral transfer of selenium in beef cattle. Am J Vet Res 51:813. PUBMED Abstract
  115. Koller LD, Whitbeck GA, South PJ. 1984. Transplacental transfer and colostral concentrations of selenium in beef cattle. Am J Vet Res 45:2507. PUBMED Abstract
  116. Roneus B, Lindholm A. 1983. Glutathione peroxidase activity in the blood of healthy horses given different selenium supplementation. Nord Vet Med 35:337. PUBMED Abstract
  117. Maas J, Peauroi JR, Tonjes T, et al. 1993. Intramuscular selenium administration in selenium-deficient cattle. J Vet Intern Med 7:342. PUBMED Abstract
  118. Roneus B. 1982. Glutathione peroxidase and selenium in the blood of healthy horses and foals affected by muscular dystrophy. Nord Vet Med 34:350. PUBMED Abstract
  119. Aharonson-Raz K, Milgram J, Chai O, et al. 2009. Fibrosis of the masseter leading to trismus and dysphagia in a mare. Vet Rec 164:597. PUBMED Abstract
  120. Pearson EG, Snyder SP, Saulez MN. 2005. Masseter myodegeneration as a cause of trismus or dysphagia in adult horses. Vet Rec 156:642. PUBMED Abstract
  121. Step DL, Divers TJ, Cooper B, et al. 1991. Severe masseter myonecrosis in a horse. J Am Vet Med Assoc 198:117. PUBMED Abstract
  122. Eckert J, Ossent P. 2006. Haycocknema-like nematodes in muscle fibres of a horse. Vet Parasitol 139:256. PUBMED Abstract
  123. Bedford HE, Valberg SJ, Firshman AM, et al. 2013. Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E-responsive muscle atrophy and weakness. J Am Vet Med Assoc 242:1127. PUBMED Abstract
  124. Elanco Products. 1980. Safety and toxicity, pp H1-H16. Elanco technical manual, ed 2. Elanco Products, Indianapolis, IN.
  125. Miller RE, Boever WJ, Junge RE, et al. 1990. Acute monensin toxicosis in Stone sheep (Ovis dalli stonei), blesbok (Damaliscus dorcus phillipsi), and a Bactrian camel (Camelus bactrianus). J Am Vet Med Assoc 196:131. PUBMED Abstract
  126. Benson JE, Ensley SM, Carson TL, et al. 1998. Lasalocid toxicosis in neonatal calves. J Vet Diagn Invest 10:210. PUBMED Abstract
  127. Helman RG, Edwards WC. 1997. Clinical features of blister beetle poisoning in equids: 70 cases (1983-1996). J Am Vet Med Assoc 211:1018. PUBMED Abstract
  128. Inns RH, Tuckwell NJ, Bright JE, et al. 1990. Histochemical demonstration of calcium accumulation in muscle fibres after experimental organophosphate poisoning. Hum Exp Toxicol 9:245. PUBMED Abstract
  129. Karalliedde L, Baker D, Marrs TC. 2006. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 25:1. PUBMED Abstract
  130. Cavaliere MJ, Calore EE, Perez NM, et al. 1996. [Organophosphate-induced myotoxicity]. Rev Saude Publica 30:267. PUBMED Abstract
  131. Myers CJ, Aleman M, Heidmann R, et al. 2006. Myopathy in American miniature horses. Equine Vet J 38:272. PUBMED Abstract
  132. Putnam MR, Boosinger T, Spano J, et al. 1988. Evaluation of Cassia obtusifolia (sicklepod) seed consumption in Holstein calves. Vet Hum Toxicol 30:316. PUBMED Abstract
  133. Beier RC, Norman JO, Irvin TR, et al. 1987. Microsomal activation of constituents of white snakeroot (Eupatorium rugosum Houtt) to form toxic products. Am J Vet Res 48:583. PUBMED Abstract
  134. Beier RC, Norman JO. 1990. The toxic factor in white snakeroot: identity, analysis and prevention. Vet Hum Toxicol 32(Suppl):81. PUBMED Abstract
  135. Thompson LJ. 1989. Depression and choke in a horse: probable white snakeroot toxicosis. Vet Hum Toxicol 31:321. PUBMED Abstract
  136. Finno CJ, Valberg SJ, Wunschmann A, et al. 2006. Seasonal pasture myopathy in horses in the midwestern United States: 14 cases (1998-2005). J Am Vet Med Assoc 229:1134. PUBMED Abstract
  137. Hillam RA. 1991. Atypical myoglobinuria. Vet Rec 128:166. PUBMED Abstract
  138. Whitwell KE, Harris P, Farrington PG. 1988. Atypical myoglobinuria: an acute myopathy in grazing horses. Equine Vet J 20:357. PUBMED Abstract
  139. Cassart D, Baise E, Cherel Y, et al. 2007. Morphological alterations in oxidative muscles and mitochondrial structure associated with equine atypical myopathy. Equine Vet J 39:26. PUBMED Abstract
  140. Gerber V, Straub R, Frey J. 2006. Equine botulism and acute pasture myodystrophy: new soil-borne emerging diseases in Switzerland? Schweiz Arch Tierheilkd 148:553. PUBMED Abstract
  141. van GG, Marcillaud PC, Saegerman C, et al. 2012. European outbreaks of atypical myopathy in grazing equids (2006-2009): spatiotemporal distribution, history and clinical features. Equine Vet J 44:614. PUBMED Abstract
  142. van GG, Saegerman C, Marcillaud PC, et al. 2012. European outbreaks of atypical myopathy in grazing horses (2006-2009): determination of indicators for risk and prognostic factors. Equine Vet J 44:621. PUBMED Abstract
  143. van GG, Cerri S, Porter S, et al. 2013. Traditional and quantitative assessment of acid-base and shock variables in horses with atypical myopathy. J Vet Intern Med 27:186. PUBMED Abstract
  144. Westermann CM, Dorland L, Votion DM, et al. 2008. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy. Neuromuscul Disord 18:355. PUBMED Abstract
  145. Sponseller BT, Valberg SJ, Schultz NE, et al. 2012. Equine multiple acyl-CoA dehydrogenase deficiency (MADD) associated with seasonal pasture myopathy in the midwestern United States. J Vet Intern Med 26:1012. PUBMED Abstract
  146. Valberg SJ, Sponseller BT, Hegeman AD, et al. 2013. Seasonal pasture myopathy/atypical myopathy in North America associated with ingestion of hypoglycin A within seeds of the box elder tree. Equine Vet J 45:419. PUBMED Abstract
  147. Rebhun WC. 1995. Diseases of dairy cattle, ed 1. Williams & Wilkins, Media, PA.
  148. Richey MT, Holland MS, McGrath CJ, et al. 1990. Equine post-anesthetic lameness. A retrospective study. Vet Surg 19:392. PUBMED Abstract
  149. White NAI. 1982. Postanesthetic recumbency myopathy in horses. Compend Cont Educ 4:544.
  150. Hennig GE, Court MH. 1991. Equine postanesthetic myopathy: an update. Compend Cont Educ 13:1709.
  151. Norman WM, Williams R, Dodman NH, et al. 1989. Postanesthetic compartmental syndrome in a horse. J Am Vet Med Assoc 195:502. PUBMED Abstract
  152. Branson KR. 1993. The hemodynamic, tissue oxygenation and selected biochemical effects of isoflurane and halothane anesthesia in horses. J Equine Vet Sci 7:396.
  153. Grandy JL, Steffey EP, Hodgson DS, et al. 1987. Arterial hypotension and the development of postanesthetic myopathy in halothane-anesthetized horses. Am J Vet Res 48:192. PUBMED Abstract
  154. Duke T, Filzek U, Read MR, et al. 2006. Clinical observations surrounding an increased incidence of postanesthetic myopathy in halothane-anesthetized horses. Vet Anaesth Analg 33:122. PUBMED Abstract
  155. McKenzie EC, Valberg SJ, Godden SM, et al. 2004. Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercise in horses with recurrent exertional rhabdomyolysis. Am J Vet Res 65:74. PUBMED Abstract
  156. Hildebrand SV, Howitt GA. 1983. Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane. Am J Vet Res 44:2280. PUBMED Abstract
  157. Manley SV, Kelly AB, Hodgson D. 1983. Malignant hyperthermia-like reactions in three anesthetized horses. J Am Vet Med Assoc 183:85. PUBMED Abstract
  158. Ward TL, Valberg SJ, Gallant EM, et al. 2000. Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis. Am J Vet Res 61:242. PUBMED Abstract
  159. Mickelson JR, Gallant EM, Litterer LA, et al. 1988. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 263:9310. PUBMED Abstract
  160. Aleman M, Brosnan RJ, Williams DC, et al. 2005. Malignant hyperthermia in a horse anesthetized with halothane. J Vet Intern Med 19:363. PUBMED Abstract
  161. Aleman M, Riehl J, Aldridge BM, et al. 2004. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve 30:356. PUBMED Abstract
  162. Bloom BA, Valentine BA, Gleed RD, et al. 1999. Postanaesthetic recumbency in a Belgian filly with polysaccharide storage myopathy. Vet Rec 144:73. PUBMED Abstract
  163. Klein L, Ailes N, Fackelman GE, et al. 1989. Postanesthetic equine myopathy suggestive of malignant hyperthermia. A case report. Vet Surg 18:479. PUBMED Abstract
  164. Valverde A, Boyd CJ, Dyson DH, et al. 1990. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. J Am Vet Med Assoc 197:1051. PUBMED Abstract
  165. Hawkins DL. 2011. The thigh, pp 550-552. In Ross M, Dyson SJ (eds), Lameness in the horse, ed 2. Elsevier, Saunders, St Louis, MO.
  166. Bishop R. 1972. Fibrotic myopathy in the gracilis muscle of a horse. Vet Med Small Anim Clin 67:270. PUBMED Abstract
  167. Dabareiner RM, Schmitz DG, Honnas CM, et al. 2004. Gracilis muscle injury as a cause of lameness in two horses. J Am Vet Med Assoc 224:1630. PUBMED Abstract
  168. Gomez-Villamandos R, Santisteban J, Ruiz I, et al. 1995. Tenotomy of the tibial insertion of the semitendinosus muscle of two horses with fibrotic myopathy. Vet Rec 136:67. PUBMED Abstract
  169. Irwin DH, Howell DW. 1981. Fibrotic myopathy, haematomas and scar tissue in the gaskin area of the Thoroughbred. J S Afr Vet Assoc 52:65. PUBMED Abstract
  170. Turner AS, Trotter GW. 1984. Fibrotic myopathy in the horse. J Am Vet Med Assoc 184:335. PUBMED Abstract
  171. Adams SB. 1999. Biology and treatment of specific muscle disorders, pp 721-726. In Auer JA, Stick JA (eds), Equine surgery, ed 2. WB Saunders, Philadelphia, PA.
  172. Bramlage LR, Reed SM, Embertson RM. 1985. Semitendinosus tenotomy for treatment of fibrotic myopathy in the horse. J Am Vet Med Assoc 186:565. PUBMED Abstract
  173. Cole FL, Mellor DJ, Hodgson DR, et al. 2004. Prevalence and demographic characteristics of exertional rhabdomyolysis in horses in Australia. Vet Rec 155:625. PUBMED Abstract
  174. Harris PA. 1991. The equine rhabdomyolysis syndrome in the United Kingdom: epidemiological and clinical descriptive information. Br Vet J 147:373. PUBMED Abstract
  175. Harris PA, Snow DH, Greet TR, et al. 1990. Some factors influencing plasma AST/CK activities in Thoroughbred racehorses. Equine Vet J Suppl:66. PUBMED Abstract
  176. McGowan CM, Fordham T, Christley RM. 2002. Incidence and risk factors for exertional rhabdomyolysis in Thoroughbred racehorses in the United Kingdom. Vet Rec 151:623. PUBMED Abstract
  177. McGowan CM, Posner RE, Christley RM. 2002. Incidence of exertional rhabdomyolysis in polo horses in the USA and the United Kingdom in the 1999/2000 season. Vet Rec 150:535. PUBMED Abstract
  178. Firshman AM, Valberg SJ, Bender JB, et al. 2003. Epidemiologic characteristics and management of polysaccharide storage myopathy in Quarter Horses. Am J Vet Res 64:1319. PUBMED Abstract
  179. Dranchak PK, Valberg SJ, Onan GW, et al. 2005. Inheritance of recurrent exertional rhabdomyolysis in Thoroughbreds. J Am Vet Med Assoc 227:762. PUBMED Abstract
  180. Grobler LA, Collins M, Lambert MI, et al. 2004. Skeletal muscle pathology in endurance athletes with acquired training intolerance. Br J Sports Med 38:697. PUBMED Abstract
  181. Valentine BA, Van Saun RJ, Thompson KN, et al. 2001. Role of dietary carbohydrate and fat in horses with equine polysaccharide storage myopathy. J Am Vet Med Assoc 219:1537. PUBMED Abstract
  182. Valentine BA, Hintz HF, Freels KM, et al. 1998. Dietary control of exertional rhabdomyolysis in horses. J Am Vet Med Assoc 212:1588. PUBMED Abstract
  183. Harris P, Colles C. 1988. The use of creatinine clearance ratios in the prevention of equine rhabdomyolysis: a report of four cases. Equine Vet J 20:459. PUBMED Abstract
  184. Beech J, Lindborg S, Braund KG. 1993. Potassium concentrations in muscle, plasma and erythrocytes and urinary fractional excretion in normal horses and those with chronic intermittent exercise-associated rhabdomyolysis. Res Vet Sci 55:43. PUBMED Abstract
  185. Valberg SJ. 2002. Diseases of muscle, pp 1272-1273. In Smith BP (ed), Large animal internal medicine, ed 3. Mosby, St Louis, MO.
  186. Roneus B, Hakkarainen J. 1985. Vitamin E in serum and skeletal muscle tissue and blood glutathione peroxidase activity from horses with the azoturia-tying-up syndrome. Acta Vet Scand 26:425. PUBMED Abstract
  187. Valberg SJ, Cardinet GH III, Carlson GP, et al. 1992. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses. Neuromuscul Disord 2:351. PUBMED Abstract
  188. Arighi M, Hulland TJ. 1984. Equine exertional rhabdomyolysis. Compend Cont Educ 1:S726.
  189. Andrews FM, Spurgeon TL, Reed SM. 1986. Histochemical changes in skeletal muscles of four male horses with neuromuscular disease. Am J Vet Res 47:2078. PUBMED Abstract
  190. Valentine BA, Credille KM, Lavoie JP, et al. 1997. Severe polysaccharide storage myopathy in Belgian and Percheron draught horses. Equine Vet J 29:220. PUBMED Abstract
  191. Valberg SJ, MacLeay JM, Billstrom JA, et al. 1999. Skeletal muscle metabolic response to exercise in horses with “tying-up” due to polysaccharide storage myopathy. Equine Vet J 31:43. PUBMED Abstract
  192. Valentine BA, McDonough SP, Chang YF, et al. 2000. Polysaccharide storage myopathy in Morgan, Arabian, and Standardbred related horses and Welsh-cross ponies. Vet Pathol 37:193. PUBMED Abstract
  193. Valentine BA, Cooper BJ. 2005. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses. Vet Pathol 42:823. PUBMED Abstract
  194. McCue ME, Valberg SJ, Miller MB, et al. 2008. Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 91:458. PUBMED Abstract
  195. McCue ME, Valberg SJ, Lucio M, et al. 2008. Glycogen synthase 1 (GYS1) mutation in diverse breeds with polysaccharide storage myopathy. J Vet Intern Med 22:1228. PUBMED Abstract
  196. McCue ME, Armien AG, Lucio M, et al. 2009. Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses. Vet Pathol 46:1281. PUBMED Abstract
  197. Carlström B. 1932. Uber die atiologie und pathogenese der kreuzlahme des pferdes (Haemaglobinaemia paralytica). Scand Archiv 62:1.
  198. Annandale EJ, Valberg SJ, Essen-Gustavsson B. 2005. Effects of submaximal exercise on adenine nucleotide concentrations in skeletal muscle fibers of horses with polysaccharide storage myopathy. Am J Vet Res 66:839. PUBMED Abstract
  199. Baird JD, Valberg SJ, Anderson SM, et al. 2010. Presence of the glycogen synthase 1 (GYS1) mutation causing type 1 polysaccharide storage myopathy in continental European draught horse breeds. Vet Rec 167:781. PUBMED Abstract
  200. McCue ME, Anderson SM, Valberg SJ, et al. 2010. Estimated prevalence of the type 1 polysaccharide storage myopathy mutation in selected North American and European breeds. Anim Genet 41(Suppl 2):145. PUBMED Abstract
  201. Stanley RL, McCue ME, Valberg SJ, et al. 2009. A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds. Equine Vet J 41:597. PUBMED Abstract
  202. McCue ME, Valberg SJ. 2007. Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States. Am J Vet Res 231:746. PUBMED Abstract
  203. McCue ME, Ribeiro WP, Valberg SJ. 2006. Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders. Equine Vet J Suppl 36:340. PUBMED Abstract
  204. Isgren CM, Upjohn MM, Fernandez-Fuente M, et al. 2010. Epidemiology of exertional rhabdomyolysis susceptibility in Standardbred horses reveals associated risk factors and underlying enhanced performance. PLoS One 5:e11594. PUBMED Abstract
  205. Firshman AM, Baird JD, Valberg SJ. 2005. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses. J Am Vet Med Assoc 227:1958. PUBMED Abstract
  206. Johlig L, Valberg SJ, Mickelson JR, et al. 2011. Epidemiological and genetic study of exertional rhabdomyolysis in a warmblood horse family in Switzerland. Equine Vet J 43:240. PUBMED Abstract
  207. Ribeiro WP, Valberg SJ, Pagan JD, et al. 2004. The effect of varying dietary starch and fat content on serum creatine kinase activity and substrate availability in equine polysaccharide storage myopathy. J Vet Intern Med 18:887. PUBMED Abstract
  208. McCue ME, Valberg SJ, Jackson M, et al. 2008. Polysaccharide storage myopathy phenotype in Quarter Horse–related breeds is modified by the presence of an RYR1 mutation. Neuromusc Disorders 19:37. PUBMED Abstract
  209. Borgia L, Valberg S, McCue M, et al. 2010. Glycaemic and insulinaemic responses to feeding hay with different non-structural carbohydrate content in control and polysaccharide storage myopathy-affected horses. J Anim Physiol Anim Nutr (Berl) 95:798. PUBMED Abstract
  210. McGowan CM, McGowan TW, Patterson-Kane JC. 2009. Prevalence of equine polysaccharide storage myopathy and other myopathies in two equine populations in the United Kingdom. Vet J 180:330. PUBMED Abstract
  211. Byrne E, Jones SL, Valberg SJ, et al. 2000. Rhabdomyolysis in two foals with polysaccharide storage myopathy and concurrent pneumonia. Comp Cont Educ Pract Vet 22:503.
  212. Hunt LM, Valberg SJ, Steffenhagen K, et al. 2008. An epidemiological study of myopathies in warmblood horses. Equine Vet J 40:171. PUBMED Abstract
  213. McCue ME, Armién AG, Lucio M, et al. 2009. Comparative skeletal muscle histopathologic and ultrastructural features in two forms of polysaccharide storage myopathy in horses. Vet Pathol 46:1281. PUBMED Abstract
  214. De La Corte FD, Valberg SJ, MacLeay JM, et al. 2002. Developmental onset of polysaccharide storage myopathy in 4 Quarter Horse foals. J Vet Intern Med 16:581. PUBMED Abstract
  215. Sprayberry KA, Madigan J, Lecouteur RA, et al. 1998. Renal failure, laminitis, and colitis following severe rhabdomyolysis in a draft horse-cross with polysaccharide storage myopathy. Can Vet J 39:500. PUBMED Abstract
  216. McGowan CM, Menzies-Gow NJ, McDiarmid AM, et al. 2003. Four cases of equine polysaccharide storage myopathy in the United Kingdom. Vet Rec 152:109. PUBMED Abstract
  217. Quiroz-Rothe E, Novales M, Guilera-Tejero E, et al. 2002. Polysaccharide storage myopathy in the M. longissimus lumborum of showjumpers and dressage horses with back pain. Equine Vet J 34:171. PUBMED Abstract
  218. Saha AK, Laybutt DR, Dean D, et al. 1999. Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo. Am J Physiol 276(6 Pt 1):E1030. PUBMED Abstract
  219. Ruderman NB, Saha AK, Vavvas D, et al. 1999. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276:E1. PUBMED Abstract
  220. McGarry JD, Brown NF. 1997. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1. PUBMED Abstract
  221. Borgia LA, Valberg SJ, McCue ME, et al. 2010. Effect of dietary fats with odd or even numbers of carbon atoms on metabolic response and muscle damage with exercise in Quarter Horse–type horses with type 1 polysaccharide storage myopathy. Am J Vet Res 71:326. PUBMED Abstract
  222. Aleman M, Lecouteur RA, Nieto JE, et al. 2005. Sarcoplasmic masses in equine skeletal muscle. Neuromuscul Disord 15:147. PUBMED Abstract
  223. Beech J. 1997. Chronic exertional rhabdomyolysis. Vet Clin North Am Equine Pract 13:145. PUBMED Abstract
  224. MacLeay JM, Sorum SA, Valberg SJ, et al. 1999. Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 60:1562. PUBMED Abstract
  225. Valberg S, Haggendal J, Lindholm A. 1993. Blood chemistry and skeletal muscle metabolic responses to exercise in horses with recurrent exertional rhabdomyolysis. Equine Vet J 25:17. PUBMED Abstract
  226. MacLeay JM, Valberg SJ, Pagan JD, et al. 2000. Effect of ration and exercise on plasma creatine kinase activity and lactate concentration in Thoroughbred horses with recurrent exertional rhabdomyolysis. Am J Vet Res 61:1390. PUBMED Abstract
  227. McKenzie EC, Valberg SJ, Godden SM, et al. 2003. Effect of dietary starch, fat, and bicarbonate content on exercise responses and serum creatine kinase activity in equine recurrent exertional rhabdomyolysis. J Vet Intern Med 17:693. PUBMED Abstract
  228. MacLeay JM, Sorum SA, Valberg SJ, et al. 1999. Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 60:1562. PUBMED Abstract
  229. Upjohn MM, Archer RM, Christley RM, et al. 2005. Incidence and risk factors associated with exertional rhabdomyolysis syndrome in National Hunt racehorses in Great Britain. Vet Rec 156:763. PUBMED Abstract
  230. Lentz LR, Valberg SJ, Herold LV, et al. 2002. Myoplasmic calcium regulation in myotubes from horses with recurrent exertional rhabdomyolysis. Am J Vet Res 63:1724. PUBMED Abstract
  231. Waldron-Mease E, Klein LV, Rosenberg H, et al. 1981. Malignant hyperthermia in a halothane-anesthetized horse. J Am Vet Med Assoc 179:896. PUBMED Abstract
  232. Lentz LR, Valberg SJ, Mickelson JR, et al. 1999. In vitro contractile responses and contracture testing of skeletal muscle from Quarter Horses with exertional rhabdomyolysis. Am J Vet Res 60:684. PUBMED Abstract
  233. Dranchak PK, Valberg SJ, Onan GW, et al. 2006. Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds. Am J Vet Res 67:1395. PUBMED Abstract
  234. Fraunfelder HC, Rossdale PD, Rickets SW. 1986. Changes in serum muscle enzyme levels in associated with training schedules and stages of oestrus cycle in Thoroughbred racehorses. Equine Vet J 18:371. PUBMED Abstract
  235. MacLeay JM, Valberg SJ, Sorum SA, et al. 1999. Heritability of recurrent exertional rhabdomyolysis in Thoroughbred racehorses. Am J Vet Res 60:250. PUBMED Abstract
  236. Fritz KL, McCue ME, Valberg SJ, et al. 2012. Genetic mapping of recurrent exertional rhabdomyolysis in a population of North American Thoroughbreds. Anim Genet 43:730. PUBMED Abstract
  237. Tozaki T, Hirota K, Sugita S, et al. 2010. A genome-wide scan for tying-up syndrome in Japanese Thoroughbreds. Anim Genet 41(Suppl 2):80. PUBMED Abstract
  238. Collinder E, Lindholm A, Rasmuson M. 1997. Genetic markers in Standardbred trotters susceptible to the rhabdomyolysis syndrome. Equine Vet J 29:117. PUBMED Abstract
  239. MacLeay JM, Valberg SJ, Pagan JD, et al. 1999. Effect of diet on Thoroughbred horses with recurrent exertional rhabdomyolysis performing a standardised exercise test. Equine Vet J Suppl 30:458. PUBMED Abstract
  240. Finno CJ, McKenzie E, Valberg SJ, et al. 2010. Effect of fitness on glucose, insulin and cortisol responses to diets varying in starch and fat content in Thoroughbred horses with recurrent exertional rhabdomyolysis. Equine Vet J Suppl 38:323. PUBMED Abstract
  241. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. 1991. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 23:219. PUBMED Abstract
  242. Lopez JR, Linares N, Cordovez G, et al. 1995. Elevated myoplasmic calcium in exercise-induced equine rhabdomyolysis. Pflugers Arch 430:293. PUBMED Abstract
  243. Edwards JG, Newtont JR, Ramzan PH, et al. 2003. The efficacy of dantrolene sodium in controlling exertional rhabdomyolysis in the Thoroughbred racehorse. Equine Vet J 35:707. PUBMED Abstract
  244. Beech J, Fletcher JE, Lizzo F, et al. 1988. Effect of phenytoin on the clinical signs and in vitro muscle twitch characteristics in horses with chronic intermittent rhabdomyolysis and myotonia. Am J Vet Res 49:2130. PUBMED Abstract
  245. Beech J. 1994. Treating and preventing chronic intermittent rhabdomyolysis. Vet Med May:458.
  246. Vischer CM, Foreman JH, Constable PD, et al. 1999. Hemodynamic effects of thyroidectomy in sedentary horses. Am J Vet Res 60:14. PUBMED Abstract
  247. Waldron-Mease E. 1979. Hypothyroidism and myopathy in racing Thoroughbreds and standardbreds. J Equine Vet Sci 3:124.
  248. Tiidus PM. 1997. Manual massage and recovery of muscle function following exercise: a literature review. J Orthop Sports Phys Ther 25:107. PUBMED Abstract
  249. Weerapong P, Hume PA, Kolt GS. 2005. The mechanisms of massage and effects on performance, muscle recovery and injury prevention. Sports Med 35:235. PUBMED Abstract
  250. Zainuddin Z, Newton M, Sacco P, et al. 2005. Effects of massage on delayed-onset muscle soreness, swelling, and recovery of muscle function. J Athl Train 40:174. PUBMED Abstract
  251. Aleman M, Nieto JE, Magdesian KG. 2009. Malignant hyperthermia associated with ryanodine receptor 1 (C7360G) mutation in Quarter Horses. J Vet Intern Med 23:329. PUBMED Abstract
  252. Valberg SJ, Carlson GP, Cardinet GH III, et al. 1994. Skeletal muscle mitochondrial myopathy as a cause of exercise intolerance in a horse. Muscle Nerve 17:305. PUBMED Abstract
  253. Wagner ML, Valberg SJ, Ames EG, et al. 2006. Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations. J Vet Intern Med 20:1207. PUBMED Abstract
  254. Valberg SJ, Ward TL, Rush B, et al. 2001. Glycogen branching enzyme deficiency in quarter horse foals. J Vet Intern Med 15:572. PUBMED Abstract
  255. Ward TL, Valberg SJ, Adelson DL, et al. 2004. Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mamm Genome 15:570. PUBMED Abstract
  256. Tsujino S, Shanske S, Valberg SJ, et al. 1996. Cloning of bovine muscle glycogen phosphorylase cDNA and identification of a mutation in cattle with myophosphorylase deficiency, an animal model for McArdle's disease. Neuromuscul Disord 6:19. PUBMED Abstract
  257. Bilstrom JA, Valberg SJ, Bernoco D, et al. 1998. Genetic test for myophosphorylase deficiency in Charolais cattle. Am J Vet Res 59:267. PUBMED Abstract
  258. Angelos S, Valberg SJ, Smith BP, et al. 1995. Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in six related Charolais cattle. Muscle Nerve 18:736. PUBMED Abstract
  259. Johnstone AC, McSporran KD, Kenny JE, et al. 2004. Myophosphorylase deficiency (glycogen storage disease type V) in a herd of Charolais cattle in New Zealand: confirmation by PCR-RFLP testing. N Z Vet J 52:404. PUBMED Abstract
  260. Tan P, Allen JG, Wilton SD, et al. 1997. A splice-site mutation causing ovine McArdle's disease. Neuromuscul Disord 7:336. PUBMED Abstract